Skip to main content
Terug
Watch Compare

Akso Health Group

Datakwaliteit: 100%
AHG
NASDAQ Services Business Services
€ 2,21
▼ € 0,15 (-6,36%)
6 months return
—
Momentum
Neutral
5Y revenue growth
70,35%

Groei

Revenue Growth (5Y)
70,35%
Boven sectorgemiddelde (3,76%)
Revenue (1Y)512,08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-68,03%
Onder sectorgemiddelde (-15,99%)
ROIC-65,92%
Net Margin-914,06%
Op. Margin-1126,52%

Veiligheid

Debt / Equity
N/A
Current Ratio1,53
Interest CoverageN/A

Waardering

PE (TTM)
-14,21
Onder sectorgemiddelde (-1,19)
P/B Ratio9,72
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 70,35% annually over 5 years — strong growth
Generating 7,23 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 441,73%
Capital efficient — spends only 0,18% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate
Q32018 Q42018 Q12019 Q22019
Reported -€ 1,08 -€ 0,60 € 0,15 -€ 0,45
Estimate — -€ 0,78 -€ 0,30 € 0,00
Verrassing — +23,08% +150,00% 0,00%

Growth

Rev 5Y: 70,35% · Earnings 1Y: N/A
Revenue Growth (1Y) 512,08% Revenue Growth (3Y) 5,88%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 70,35% Earnings Growth (5Y) N/A

Profitability

ROE: -68,03% · Net Margin: -914,06%
Revenue (TTM) 14,84 M Net Income (TTM) -135,67 M
ROE -68,03% ROA -63,84%
Gross Margin 1,00% Operating Margin -1126,52%
Net Margin -914,06% Free Cash Flow (TTM) 7,23 M
ROIC -65,92% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,53
Debt / Equity N/A Current Ratio 1,53
Interest Coverage N/A Asset Turnover 0,07
Working Capital 6,37 M Tangible Book Value 180,41 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs

Valuation

P/E: -14,21 · EV/EBITDA: N/A
P/E Ratio -14,21 Forward P/E N/A
P/B Ratio 9,72 P/S Ratio 129,87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,38%
Market Cap 1,93 B Enterprise Value 1,92 B

Per Share

EPS: -0,16 · FCF/Share: 0,01
EPS (Diluted TTM) -0,16 Revenue / Share 0,02
FCF / Share 0,01 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -5,33% · CapEx/Rev: 0,18%
CapEx / Revenue 0,18% FCF Conversion -5,33%
SBC-Adj. FCF 6,84 M Growth Momentum 441,73

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 14,78 M 2,41 M 13,18 M 6,31 M 1,75 M
Net Income -134,98 M -9,46 M -1,36 M -16,85 M -34,83 M
EPS (Diluted) -0,16 -0,07 -0,02 -0,28 -0,71
Gross Profit -281.526,0 122.132,0 1,27 M 916.226,0 —
Operating Income -166,30 M -8,64 M -14,27 M -15,94 M -30,90 M
EBITDA — — — — —
R&D Expenses — — — 421.186,0 441.405,0
SG&A Expenses 3,64 M — — — —
D&A 2,15 M — — 18.390,0 15.161,0
Interest Expense — 804.138,0 804.138,0 — —
Income Tax -30,80 M 24.988,0 17.549,0 131.433,0 482.976,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 214,95 M 142,02 M 20,46 M 50,68 M 31,69 M
Total Liabilities 15,80 M 3,59 M 11,62 M 38,39 M 14,41 M
Shareholders' Equity 199,12 M 138,37 M 8,73 M 12,28 M 17,27 M
Total Debt — — — — —
Cash & Equivalents 176,23 M 85,17 M 7,92 M 21,93 M 15,13 M
Current Assets 196,12 M 142,02 M 20,46 M 50,62 M 30,12 M
Current Liabilities 13,81 M 3,59 M 11,62 M 38,39 M 14,41 M

Sectorvergelijking

vs Services sector mediaan (615 peers)
Metriek Aandeel Sector Mediaan
P/E -14,2 -1,2
P/B 9,7 1,4
ROE % -68,0 -16,0
Net Margin % -914,1 -19,4
Rev Growth 5Y % 70,4 3,8
D/E — 0,4

Dividendgeschiedenis

Recente betalingen per aandeel (nieuwste eerst).

Ex-dividend Betaling Bedrag / aandeel
Aug 01, 2018 — € 1,20